Tansna Therapeutics, Inc. — Form D

Tansna Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-25. The offering totals $850K. Industry: Biotechnology.

Offering

• Filed: 2013-09-25
• Form: D
• Accession: 0001587426-13-000001
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $850K
• Remaining: $850K
• Minimum investment: $50K
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-203528

Issuer

• Name: Tansna Therapeutics, Inc.
• CIK: 0001587426
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2010
• Address: 4320 FOREST PARK AVENUE, ST. LOUIS, MO, 63108
• Phone: 8609382315

Officers, directors & promoters (7)

More

• CIK 1587426 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search